Market Tracker

03/27 7:45pm ET

EPIRUS Biopharmaceuticals Inc (NASDAQ:EPRS)

9.03
Delayed Data
As of Mar 27
 -0.14 / -1.53%
Today’s Change
3.78
Today|||52-Week Range
17.40
+59.26%
Year-to-Date

Today’s Trading

Previous close9.17
Today’s open9.23
Day’s range8.91 - 9.29
Volume179,766
Average volume (3 months)308,333
Market cap$203.5M
Dividend yield--
Data as of 3:59pm ET, 03/27/2015

Growth & Valuation

Earnings growth (last year)+26.32%
Earnings growth (this year)+82.35%
Earnings growth (next 5 years)--
Revenue growth (last year)+17.38%
P/E ratioNM
Price/Sales1.73
Price/Book1.66

Competitors

 Today’s
change
Today’s
% change
ALIMAlimera Sciences Inc+0.21+4.79%
AGRXAgile Therapeutics I...+0.34+3.82%
ZGNXZogenix Inc+0.03+2.29%
GALEGalena Biopharma Inc-0.03-2.17%
Data as of 3:59pm ET, 03/27/2015

Financials

Last reporting dateMarch 23, 2015
EPS forecast (this quarter)-$0.99
Annual revenue (last year)$14.7M
Annual profit (last year)-$38.6M
Net profit margin-262.15%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Amit D. Munshi
Chief Financial Officer &
Treasurer
Thomas A. Shea
Corporate headquarters
Boston, Massachusetts

Forecasts